Evidence map›Paper›PMID 29029636›Full record

ArticleBreast cancer research : BCR2017

Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.

Katherine Lawler, Efterpi Papouli, Cristina Naceur-Lombardelli, Anca Mera, Kayleigh Ougham, Andrew Tutt, Siker Kimbung, Ingrid Hedenfalk, Jun Zhan, Hongquan Zhang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review of the premetastatic niche in liver cancer bone metastases.International journal of clinical and experimental pathology · 2026
    Review
  2. Organ-Specificity of Breast Cancer Metastasis.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Katherine LawlerSchool of Cancer Studies, CRUK King's Health Partners Centre, King's College London, Guy's Campus, London, SE1 1UL, UK.
Efterpi PapouliNIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, WC2R 2LS, UK.
Cristina Naceur-LombardelliResearch Oncology, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, SE1 9RT, UK.
Anca MeraResearch Oncology, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, SE1 9RT, UK.
Kayleigh OughamCancer Bioinformatics, King's College London, Innovation Centre, Cancer Centre at Guy's Hospital, London, SE1 9RT, UK.
Andrew TuttBreast Cancer Now Research Unit, Innovation Centre, Cancer Centre at Guy's Hospital, King's Health Partners AHSC, King's College London, Faculty of Life Sciences and Medicine, London, SE1 9RT, UK.
Siker KimbungDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Ingrid HedenfalkDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Jun ZhanKey Laboratory of Carcinogenesis and Translational Research, Ministry of Education of Beijing, Beijing, People's Republic of China, Laboratory of Molecular Cell Biology and Tumor Biology, Department of Anatomy, Histology and Embryology, Peking University Health Science Center, Beijing, People's Republic of China.
Hongquan ZhangKey Laboratory of Carcinogenesis and Translational Research, Ministry of Education of Beijing, Beijing, People's Republic of China, Laboratory of Molecular Cell Biology and Tumor Biology, Department of Anatomy, Histology and Embryology, Peking University Health Science Center, Beijing, People's Republic of China.
Richard BuusThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Mitch DowsettThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Tony NgSchool of Cancer Studies, CRUK King's Health Partners Centre, King's College London, Guy's Campus, London, SE1 1UL, UK.
Sarah E PinderResearch Oncology, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, SE1 9RT, UK.
Peter ParkerSchool of Cancer Studies, CRUK King's Health Partners Centre, King's College London, Guy's Campus, London, SE1 1UL, UK.
Lars HolmbergCancer Epidemiology Unit, King's College London, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
Cheryl E GillettResearch Oncology, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, SE1 9RT, UK.
Anita GrigoriadisSchool of Cancer Studies, CRUK King's Health Partners Centre, King's College London, Guy's Campus, London, SE1 1UL, UK. anita.grigoriadis@kcl.ac.uk.ORCID http://orcid.org/0000-0003-3434-201X
Arnie PurushothamSchool of Cancer Studies, CRUK King's Health Partners Centre, King's College London, Guy's Campus, London, SE1 1UL, UK. EA-Purushotham@kcl.ac.uk.
Guy's Hospital · GBInstitute of Cancer Research · GBKing's College London · GBLund University · SEPeking University · CNThe Honourable Society of Lincoln's Inn · GB

Funding

Cancer Research UK 16463
6 · The paper itself

Abstract

backgroundMetastases from primary breast cancers can involve single or multiple organs at metastatic disease diagnosis. Molecular risk factors for particular patterns of metastastic spread in a clinical population are limited.

methodsA case-control design including 1357 primary breast cancers was used to study three distinct clinical patterns of metastasis, which occur within the first six months of metastatic disease: bone and visceral metasynchronous spread, bone-only, and visceral-only metastasis. Whole-genome expression profiles were obtained using whole genome (WG)-DASL assays from formalin-fixed paraffin-embedded (FFPE) samples. A systematic protocol was developed for handling FFPE samples together with stringent data quality controls to identify robust expression profiling data. A panel of published and novel gene sets were tested for association with these specific patterns of metastatic spread and odds ratios (ORs) were calculated.

resultsMetasynchronous metastasis to bone and viscera was found in all intrinsic breast cancer subtypes, while immunohistochemically (IHC)-defined receptor status and specific IntClust subgroups were risk factors for visceral-only or bone-only first metastases. Among gene modules, those related to proliferation increased the risk of metasynchronous metastasis (OR (95% CI) = 2.3 (1.1-4.8)) and visceral-only first metastasis (OR (95% CI) = 2.5 (1.2-5.1)) but not bone-only metastasis (OR (95% CI) = 0.97 (0.56-1.7)). A 21-gene module (BV) was identified in estrogen-receptor-positive breast cancers with metasynchronous metastasis to bone and viscera (area under the curve = 0.77), and its expression increased the risk of bone and visceral metasynchronous spread in this population. BV was further orthogonally validated with NanoString nCounter in primary breast cancers, and was reproducible in their matched lymph nodes metastases and an external cohort.

conclusionThis case-control study of WG-DASL global expression profiles from FFPE tumour samples, after careful quality control and RNA selection, revealed that gene modules in the primary tumour have differing risks for clinical patterns of metasynchronous first metastases. Moreover, a novel gene module was identified as a putative risk factor for metasynchronous bone and visceral first metastatic spread, with potential implications for disease monitoring and treatment planning.

Indexed as

AgedBone NeoplasmsBreast NeoplasmsCase-Control StudiesFemaleFormaldehydeGene Expression ProfilingGene Expression Regulation, NeoplasticHumansLymphatic MetastasisMiddle AgedNeoplasm ProteinsOligonucleotide Array Sequence AnalysisOrgans at RiskParaffin EmbeddingPrognosisFormaldehydeNeoplasm ProteinsBreast cancerGene expression patternMetasynchronous metastases

Identifiers

PMID29029636
PMCPMC5640935
OpenAlexW2763130803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.